Cytokines modulate integrin α(v)β3-mediated human endothelial cell adhesion and calcium signaling

Experimental Cell Research

Volumn 251, Issue 1, 1999, Pages 57-66

  Yeh, Chia Hsin ^a   Peng, Hui Chin ^a   Huang, Tur Fu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Cytokines; Disintegrin; Tumor necrosis factor; (v) 3 integrin

Indexed keywords

CYTOKINE; DISINTEGRIN; FIBROBLAST GROWTH FACTOR; INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

EID: 0033603888     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4560     Document Type: Article

References (50)

1. Folkman J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1995;1757-1763.
2. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
3. Ingber D. E., Folkman J. How does extracellular matrix control capillary morphogenesis? Cell. 58:1989;803-805.
4. Enenstein J., Waleh N. S., Kramer R. H. Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp. Cell Res. 203:1992;499-503.
5. Klein S., Giancotti F. G., Presta M., Albelda S. M., Buck C. A., Rifkin D. B. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell. 4:1993;973-982.
6. Hynes R. O. Integrins: Versatiltiy, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
7. Bischoff J. Cell adhesion and angiogenesis. J. Clin. Invest. 99:1997;373-376.
8. Shattil S. J. Function and regulation of β3 integrin in hemostasis and vascular biology. Thromb. Haemostasis. 74:1995;149-155.
9. Brooks P. C., Clark R. A. F., Cheresh D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science. 264:1994;569-571.
10. Friedlander M., Brooks P. C., Shaffer R. W., Kincaid C. M., Varner J. A., Cheresh D. A. Definition of two angiogenic pathways by distinct αv integrins. Science. 270:1995;1550-1502.
11. Stromblad S., Cheresh D. A. Cell adhesion and angiogenesis. Trends Cell Biol. 6:1996;462-468.
12. Varner J. A., Cheresh D. A. Integrin and cancer. Curr. Opin. Cell Biol. 8:1996;724-730.
13. Leavesley P. I., Schwartz M. A., Rosenfeld M., Cheresh D. A. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121:1993;163-170.
14. WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J. Clin. Invest. 98:1996;426-433.
15. Byzova T. V., Rabbani R., D'Souza S. E., Plow E. Role of integrin αvβ3 in vascular biology. Thromb. Haemostasis. 80:1998;726-734.
16. Gould R. J., Polokoff M. A., Friedman P. A., Huang T. F., Holt J. C., Cook J. J., Niewiarowski S. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 195:1990;168-171.
17. Kumar C. C., Nie H., Rogers C. P., Malkowsky M., Maxwell E., Catino J. J., Armstrong L. Biochemical characterization of the binding of echistatin to integrin αvβ3 receptor. J. Pharmacol. Exp. Ther. 283:1997;843-853.
18. Juliano D., Wang Y., Marcinkiewicz C., Rosenthal L. A., Stewart G. J., Niewiarowski S. Disintegrin interaction with αvβ3 integrin on human umbilical vein endothelial cells: Expression of ligand-induced binding site on β3 subunit. Exp. Cell Res. 255:1996;132-142.
19. Yeh C. H., Peng H. C., Huang T. F. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin αvβ3 antagonist and inducing apoptosis. Blood. 92:1998;3268-3276.
20. Chang H. H., Chang C. P., Chang J. C., Dung S. Z., Lo S. J. Application of recombinant rhodostomin in studying cell adhesion. J. Biomed. Sci. 4:1997;235-243.
21. Huang T. F., Wang W. J., Teng C. M., Lieu C. S., Ouyang C. Purification and characterization of a antiplatelet peptide, arietin, from Bitis arietans venom. Biochim. Biophys. Acta. 1074:1991;136-143.
22. Huang, T. F, Ouyang, C, and, Teng, C. M. 1990, Rhodostomin, a snake venom peptide and its fragment inhibit platelet aggregation by acting as fibrinogen receptor antagonist, 11th International Congress on Thrombosis, Ljubljana, Yogoslavia. [abstract 141].
23. Coller B. S. A new murin monoclonal antibody reports on activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J. Clin. Invest. 76:1985;101-108.
24. Frelinger III A. L., Cohen I., Plow E. F., Smith M. A., Robert J., Lam S. C. T., Ginsberg M. H. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J. Biol. Chem. 265:1990;6346-6352.
25. Cheresh D. A. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc. Natl. Sci. USA. 84:1987;6471-6475.
26. Leavesley D. I., Schwartz M. A., Rosenfeld M., Cheresh D. A. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121:1993;163-170.
27. Liu C. Z., Wang Y. W., Shen M. C., Huang T. F. Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb. Haemostasis. 72:1994;919-925.
28. Jaffe E. A., Nachamn R. L., Becker C. G., Minnick C. R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:1973;2745-2756.
29. Yeh C. H., Peng H. C., Yih J. B., Huang T. F. A new short chain RGD-containing disintegrin, accutin, inhibits the common pathway of human platelet aggregation. Biochim. Biophys. Acta. 1425:1998;493-504.
30. Mason J. Do adhesion molecules signal via FGF receptors? Curr. Biol. 4:1994;1158-1161.
31. Schwartz M. A., Schaller M. D., Ginsberg M. H. Integrins: Emerging paradigms of signal transduction. Annu. Rev. Cell Biol. 11:1995;549-599.
32. Smith J. W., Piotrowicz R. S., Mathis D. A mechanism for divalent cation regulation of β3-integrin. J. Biol. Chem. 269:1994;960-967.
33. Burgering B. M., Coffer P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
34. Huang T. F., Holt J. C., Lukasiewicz H., Niewiarowski S. Trigramin, a low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J. Biol. Chem. 262:1987;16157-16163.
35. Huang T. F., Liu C. Z. The biological activities of disintegrins and their possible applications. J. Toxicol.-Toxin Rev. 16:1997;135-161.
36. Huang T. F. What have snakes taught us about integrins? Cell. Mol. Life Sci. 54:1998;527-540.
37. Chang H. H., Lo S. J. Full-spreading platelets induced by the recombinant rhodostomin are via binding to integrins and correlated with FAK phosphorylation. Toxicon. 36:1998;1087-1099.
38. Folkman J., Klagsbrum M. Angiogenic factors. Science. 235:1987;442-447.
39. Robaye B., Mosselmans R., Fiers W., Dumont J. E., Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138:1991;447-453.
40. Plopper G. E., McNamee H. P., Dike L. E., Bojanowski K., Ingber D. E. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell. 6:1995;1349-1365.
41. Hughes P. E., Pfaff M. Integrin affinity modulation. Trends Cell Biol. 8:1998;359-364.
42. Smith S. S., Joneckis C. C., Parise L. V. Regulation of vascular integrins. Blood. 81:1993;2827-2843.
43. Byzova T. V., Plow E. F. Activation of αvβ3 on vascular cells controls recognition of prothrombin. J. Cell Biol. 143:1998;2081-2092.
44. Ruegg C., Yimaz A., Bieler G., Bamat J., Chaubert P., Lejeune F. J. Evidence for the involvement of endothelial cell integrin αvβ3 in the disruption of tumor vasculature induced by TNF and INF-γ Nature Med. 4:1998;408-414.
45. Pelletier A. J., Kunicki T., Quaranta V. Activation of the integrin αvβ3 involves a discrete cation-binding site that regulates conformation. J. Biol. Chem. 271:1996;1364-1370.
46. Defilippi P., Truffa G., Stefanuto G., Altruda F., Silengo L., Tarone G. Tumor necrosis factor α and interferon γ modulate the expression of the vitronectin receptor (integrin β3) in human endothelial cells. J. Biol. Chem. 266:1991;7638-7645.
47. Beacham D. A., Tran L. P., Shapiro S. S. Cytokines treatment of endothelial cells increases glycoprotein Ibα-dependent adhesion to von Willebrand factor. Blood. 89:1997;4071-4077.
48. Shimizu Y., Hunt S. W. Regulating integrin-mediated adhesion: one more function for PI-3 kinase? Immunol. Today. 17:1996;565-573.
49. Zhang J., Shattil S. J., Cunningham M. C., Rittenhouse S. E. Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of αIIbβ3 integrin. J. Biol. Chem. 271:1996;6265-6272.
50. Eliceiri B. P., Klemke R., Stromblad S., Cheresh D. A. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140:1998;1255-1263.